Pharmacokinetics of diphenylboroxazolidones of L-α-amino acids with activity on the CNS: Quantification in rat DBS by UPLC-MS/MS

Bioanalysis

Volumn 3, Issue 4, 2011, Pages 439-448

  González, Alberto Garcáa ^a   Zavala, Leticia Contreras ^b   Moreno, Alionka P Angeles ^b   San Juan, Eduardo Ramárez ^a   Ferrara, José G Trujillo ^a   Espinosa, Liliana Rivera ^c   Jiméez, Gabriel Marcelán ^d  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b Global Bioanalytical Consulting   (Mexico)

^c Inst Nac de Cardiolog   (Mexico)

^d HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO ACID; ASPARTIC ACID; BORON; DIPHENYLBOROXAZOLIDONE DERIVATIVE; GLUTAMIC ACID; GLYCINE; OXAZOLIDINONE DERIVATIVE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BIOLOGICAL ACTIVITY; CENTRAL NERVOUS SYSTEM; CHEMICAL REACTION; CHROMATOGRAPHY; CONTROLLED STUDY; DRIED BLOOD SPOT; DRUG CLEARANCE; DRUG ELIMINATION; DRUG STRUCTURE; GAS FLOW; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIPOPHILICITY; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; QUALITY CONTROL; RAT; ROOM TEMPERATURE; SENSITIVITY AND SPECIFICITY; SYNTHESIS; TANDEM MASS SPECTROMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

AMINO ACIDS; ANIMALS; BLOOD SPECIMEN COLLECTION; BORON COMPOUNDS; CENTRAL NERVOUS SYSTEM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; MALE; OXAZOLIDINONES; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 79952011639     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.10.208     Document Type: Article

References (10)

1. Yang W, Gao X, Wang B. Borinic acid compounds as potential pharmaceutical agents. Med. Res. Rev. 23, 346-368 (2003). (Pubitemid 36457539)
2. Jabbour A, Steinberg D, Dembitsky VM et al. Synthesis and evaluation of oxazaborolidines for antibacterial activity against Streptococcus mutans. J. Med. Chem. 47, 2409-2410 (2004). (Pubitemid 38580076)
3. Velasco B, Trujillo-Ferrara JG, Castillo LH et al. In vitro apoptotic activity of 2,2-diphenyl- 1,3,2-oxaborolidin-5-ones in L5178Y cells. Life Sci. 80, 1007-1013 (2007). (Pubitemid 46210064)
4. Soloway AH, Tjarks W, Barnum BA et al. The chemistry of neutron capture therapy. Chem. Rev. 98, 1515-1562 (1998). (Pubitemid 128635962)
5. Petasis NA. Expanding roles for organoboron compounds - versatile and valuable molecules for synthetic, biological, and medicinal chemistry. Aust. J. Chem. 60, 795-798 (2007). (Pubitemid 350050541)
6. Dembitsky VM, Srebnik M. Synthesis and biological activity of α-aminoborinic acids , amine-carboxyboranes and their derivatives. Tetrahedron 59, 579-593 (2003). (Pubitemid 36124016)
7. Araujo AJ, Querejeta E, Oviedo A et al. (+)-(S)-trujillon, (+)-(S)-4-(2,2-diphenyl- 1,3,2-oxazabolidin-5-oxo)propionic acid, a novel glutamatergic analog, modifies the activity of globus pallidus neurons by selective NMDA receptor activation. Chirality 16, 586-591 (2004).
8. Strang CJ, Henson E, Okamoto Y et al. Separation and determination of a-amino acids by boroxazolidone formation. Anal. Biochem. 178, 276-286 (1989). (Pubitemid 19125347)
9. Li W, Tse FL. Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. Biomed. Chromatogr. 24(1), 49-65 (2010).
10. US Department of Health and Human Services: Food and Drug Administration, Center of Drug Evaluation and Research, Center of Veterinary Medicine. Guidance for Industry: Bioanalytical Method Validation. Rockville, IN, USA (2001).